Press releases | WebDisclosure

Basculer en Français

10189	Companies
209749	Keywords
139909	Articles
111226	Press releases

Home
Press releases

PRESS RELEASE

published on 09/17/2025 at 07:30, 6 months 25 days ago

Informations privilégiées / Communiqué sur comptes, résultats
Sensorion présente ses résultats du premier semestre 2025, activités de thérapie génique SENS-501, GJB2-GT et SENS-401, annonce dépôts réglementaires et études cliniques en cours

Résultats Thérapie Génique Études Cliniques Dépôts Réglementaires Sensorion
PRESS RELEASE

published on 09/17/2025 at 07:30, 6 months 25 days ago

Informations privilégiées / Information sur chiffre d’affaires annuel
MaaT Pharma publie ses résultats semestriels 2025 et réalise un point sur ses activités, incluant des résultats positifs d'essais cliniques et des accords stratégiques, renforçant sa position financière et opérationnelle

Résultats Semestriels Essais Cliniques Position Financière MaaT Pharma Accords Stratégiques
PRESS RELEASE

published on 09/17/2025 at 07:30, 6 months 25 days ago

Inside Information / Information on annual revenues
MaaT Pharma presents positive Half Year 2025 Results with promising data from Phase 3 trial of MaaT013 in aGvHD. Company strengthens position with partnerships and financing

Partnerships Phase 3 Trial Half Year Results MaaT Pharma AGvHD
PRESS RELEASE

published on 09/17/2025 at 07:30, 6 months 25 days ago

Inside Information / News release on accounts, results
Sensorion reports 2025 half-year results, corporate update, and availability of half-year report. Progress in gene therapy programs for hearing loss disorders discussed

Clinical Trials Gene Therapy Sensorion Hearing Loss Disorders 2025 Half-Year Results
PRESS RELEASE

published on 09/17/2025 at 07:00, 6 months 25 days ago

Informations privilégiées / Communiqué sur comptes, résultats
PRESS RELEASE

published on 09/17/2025 at 07:00, 6 months 25 days ago

Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study
Sanofi's brivekimig shows positive results in phase 2a study for hidradenitis suppurativa, presenting clinically meaningful improvements in primary and secondary endpoints in biologic-naïve patients

Sanofi Brivekimig Hidradenitis Suppurativa Phase 2a Study Immune-mediated Diseases
PRESS RELEASE

published on 09/17/2025 at 06:56, 6 months 25 days ago

EQS-Adhoc: Adtran Holdings, Inc.: ADTRAN Holdings, Inc. Prices Upsized USD 175.0 Million Convertible Senior Notes Offering
ADTRAN Holdings, Inc. prices upsized USD 175.0 million convertible senior notes offering. The offering includes 3.75% convertible senior notes due 2030

ADTRAN Holdings Senior Notes Private Offering Convertible USD 175.0 Million
PRESS RELEASE

published on 09/17/2025 at 06:45, 6 months 25 days ago

Debt moratorium for Swiss companies of the Meyer Burger Group published
Meyer Burger Group continues debt moratorium for Swiss companies due to failed investor search. Delisting proceedings initiated by SIX Exchange Regulation AG

Delisting Bankruptcy Debt Moratorium Meyer Burger Group Investor Search
PRESS RELEASE

published on 09/17/2025 at 06:30, 6 months 25 days ago

Horus Pharma becomes additional commercialization partner for Formycon's Eylea® biosimilar FYB203 in selected European countries under the brand name Baiama®
Horus Pharma partners with Formycon for Eylea biosimilar commercialization in Europe under Baiama brand. Agreement includes upfront payments and royalties for Klinge. Aflibercept treats nAMD

Agreement Formycon Eylea Biosimilar Horus Pharma Baiama Brand
PRESS RELEASE

published on 09/17/2025 at 02:01, 6 months 25 days ago

A2Z Cust2Mate Solutions Corp. Announces Pricing of US$45 Million Upsized and Oversubscribed Public Offering of Common Shares
A2Z Cust2Mate Solutions Corp. announces pricing of upsized public offering led by institutional investors. Proceeds to fuel company's growth and expansion plans

Expansion Institutional Investors Growth Public Offering A2Z Cust2Mate Solutions Corp.

Accesswire

Published on 04/11/2026 at 02:00, 1 day 8 hours ago

Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 04/11/2026 at 01:40, 1 day 9 hours ago

Arctic Fox Announces Closing of Final Tranche Of Non-Brokered Private Placement
Published on 04/11/2026 at 00:30, 1 day 10 hours ago

Trans Canada Gold Corp. Announces Proposed Warrant Extension
Published on 04/10/2026 at 23:30, 1 day 11 hours ago

Clean Air Metals Announces Management Changes
Published on 04/10/2026 at 23:15, 1 day 11 hours ago

Gemdale Announces Change of Corporate Secretary

View all ACCESSWIRE

EQS Group

Published on 04/11/2026 at 16:45, 18 hours 6 minutes ago

CGTN: One family: Xi Jinping stresses keeping future of cross-Strait ties in Chinese hands
Published on 04/11/2026 at 16:40, 18 hours 11 minutes ago

VARON Delivers Advanced Portable Oxygen Concentrator to Meet Rising Demand in Europe
Published on 04/11/2026 at 16:30, 18 hours 21 minutes ago

VARON Oxygen Concentrators Meet Rising Demand for Modern Oxygen Therapy in Germany
Published on 04/10/2026 at 19:00, 1 day 15 hours ago

EPIC Suisse AG – Annual General Meeting 2026 approves all proposals by the Board of Directors
Published on 04/10/2026 at 18:30, 1 day 16 hours ago

AGM 2026 - Bossard Holding AG Press Release

Les Echos

Published on 04/11/2026 at 16:29, 18 hours 22 minutes ago

Décès de Madame Jacqueline Himsworth, Présidente du Conseil d’administration de Manitou Group
Published on 04/11/2026 at 16:29, 18 hours 22 minutes ago

Passing of Madame Jacqueline Himsworth, Chairman of the Board of Directors of Manitou Group
Published on 04/10/2026 at 18:35, 1 day 16 hours ago

Disclosure of trading own shares
Published on 04/10/2026 at 18:35, 1 day 16 hours ago

Déclaration des transactions sur actions propres
Published on 04/10/2026 at 18:26, 1 day 16 hours ago

EURAZEO ANNOUNCES THE SUCCESS OF ITS INAUGURAL 500 MILLION EURO BOND ISSUE

View all LES ECHOS COMFI WIRE